【一季度末社保基金持有多只创新药概念股】 多只创新药概念股获得社保基金青睐。统计显示,今年一季报共有15股获得社保基金重仓,合计持股市值达到41.02亿元,其中6只个股为第一季度新进重仓。我武生物、泰格医药、泽璟制药-U获社保基金持股市值居前,分别为5.55亿元、4.88亿元、4.75亿元。

金融界
30 May
多只创新药概念股获得社保基金青睐。统计显示,今年一季报共有15股获得社保基金重仓,合计持股市值达到41.02亿元,其中6只个股为第一季度新进重仓。我武生物泰格医药泽璟制药-U获社保基金持股市值居前,分别为5.55亿元、4.88亿元、4.75亿元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10